Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Drug Use Investigation of Enbrel for Post-Marketing Surveillance.

Trial Profile

A Drug Use Investigation of Enbrel for Post-Marketing Surveillance.

Phase of Trial: Phase IV

Latest Information Update: 14 Aug 2013

At a glance

  • Drugs Etanercept (Primary)
  • Indications Juvenile rheumatoid arthritis; Psoriatic arthritis; Rheumatoid arthritis
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors Wyeth
  • Most Recent Events

    • 28 Mar 2012 Actual patient number is 487 according to ClinicalTrials.gov.
    • 28 Mar 2012 Actual end date changed from Aug 2009 to Feb 2008 as reported by ClinicalTrials.gov.
    • 22 Sep 2009 Actual end date (Aug 2009) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top